Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems, Eurogentec Ink Probe Manufacturing Pact

NEW YORK (GenomeWeb News) – Belgian reagents manufacturer Eurogentec today said that it has licensed from Life Technologies business Applied Biosystems the rights to manufacture and sell dual-labeled oligonucleotide probes worldwide for use in the 5' nuclease process.

The agreement was signed under AB's Probe Manufacturing License Program and provides Eurogentec with limited pass-through use rights to its research customers. It also provides Eurogentec with rights under several probe composition and method patents to offer oligo design services for probes and primers for use in real-time PCR.

The agreement "confirms the validity of our previous investments in PCR and real-time PCR," Eurogentec CSO Philippe Cronet said in a statement. "In addition to the benefits for the research market, the new agreement is an important cornerstone in our on-going commitment to serve the commercial molecular diagnostic assay market."

Financial terms of the agreement were not disclosed.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.